We are one of the oldest and largest Divisions of Clinical Pharmacology in the world. Founded in 1963, the scientific mission of the division is to understand mechanisms of drug action in humans in order to improve therapeutics. As such, our research bridges basic pharmacology and the clinical sciences. The division is unique in that it is a component of two departments-Internal Medicine and Pharmacology and, consequently, is uniquely poised to make significant advances in both basic and translational research. Clinical Pharmacology at Vanderbilt is vibrant. With over 35 faculty and 35 postdoctoral fellows, members of the division are engaged in a wide variety of research efforts. The division integrates with other efforts in the pharmacological sciences at Vanderbilt including the Department of Pharmacology, the Vanderbilt Institute for Chemical Biology, and the Center in Molecular Toxicology.
The six main areas of research interest within the division include: Pharmacogenetics and drug disposition and metabolism. Fatty acid oxidation and lipid mediator pharmacology. Ion channel pharmacology and arrhythmia pharmacogenomics. Human cardiovascular pharmacology and autonomic dysfunction. Bone and cancer pharmacology. Pharmacoepidemiology.
We invite you to explore our website and the division in order to gain a better understanding of the opportunities available for research in Clinical Pharmacology at Vanderbilt. Director: Nancy J. Brown, M.D.
Chief of Division of Clinical Pharmacology
|